Sirio’s board has approved a potential total investment of up to $40 million for the project SIRIO Pharma (SIRIO) the global nutraceutical contract development and manufacturing organisation (CDMO) announces plans to commence work on a new production site in Chonburi, Thailand. After record revenues during 2023, Sirio announced in May 2024 a[Read More…]
Tag: Alex Du
Navigating regulatory maze primary challenges facing nutraceuticals in Asia
Alex Du, General Manager of the APAC Business Unit at Sirio Pharma Co., Ltd, In Asia, one of the primary challenges is the regulatory complexities across different regions. The rules governing nutraceuticals are not well defined in some areas, making compliance and market entry difficult. Quality control is another potential[Read More…]
